Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 2/2014

01.02.2014 | Original Paper

Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography

verfasst von: Hoyoun Won, Jung-Sun Kim, Dong-Ho Shin, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The use of drug-eluting stent (DES) has been associated with incomplete endothelialization and coronary endothelial dysfunction. However, the relationship between endothelial vasomotor function and strut coverage evaluated by optical coherence tomography (OCT) has not been sufficiently assessed. Therefore, we evaluated the relationship between endothelial vasomotor function and the degree of stent strut coverage after DES implantation. Coronary angiography and OCT were performed in 112 patients at the 6-month follow-up after DES implantation. The patients were divided into tertiles according to the degree of strut coverage as was assessed by OCT. Endothelial vasomotor function was evaluated with intracoronary infusion of incremental doses of acetylcholine (Ach; 10−8–10−6 mol/L). Vascular responses at the proximal and distal segments to the stent margin were evaluated by quantitative coronary angiography analysis before and after Ach infusion. The percentage of uncovered struts in tertiles 1–3 was 4.2 ± 3.3, 17.3 ± 4.2 and 44.5 ± 14.4 %, respectively, (p < 0.001). The percentage of maximal vasoconstriction in tertiles 1–3 was 8.3, 9.1 and 8.1 % at proximal segment to the stent margin (p = 0.95), respectively, and 13.9, 11.1 and 14.2 % at distal segment to the stent margin (p = 0.74), respectively. The percentage of uncovered struts was not correlated with the degree of vasomotor function (r = −0.01, p = 0.92 at the proximal segment; r = −0.07, p = 0.47 at the distal segment). The percentage of strut coverage was not associated with the degree of abnormal vasoconstriction in response to intracoronary infusion of Ach 6 months after DES implantation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Muhlestein JB (2008) Endothelial dysfunction associated with drug-eluting stents what, where, when, and how? J Am Coll Cardiol 51:2139–2140PubMedCrossRef Muhlestein JB (2008) Endothelial dysfunction associated with drug-eluting stents what, where, when, and how? J Am Coll Cardiol 51:2139–2140PubMedCrossRef
2.
Zurück zum Zitat Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, Nedeljkovic M, Orlic D, Milosavljevic B, Topic D, Karanovic N, Wijns W, Nobori Core investigators (2008) Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J Am Coll Cardiol 51:2123–2129PubMedCrossRef Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, Nedeljkovic M, Orlic D, Milosavljevic B, Topic D, Karanovic N, Wijns W, Nobori Core investigators (2008) Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J Am Coll Cardiol 51:2123–2129PubMedCrossRef
3.
Zurück zum Zitat Joner M, Finn AV, Farb A, Mont KE, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRef Joner M, Finn AV, Farb A, Mont KE, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRef
4.
Zurück zum Zitat Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr (2004) Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930–1932PubMedCrossRef Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr (2004) Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930–1932PubMedCrossRef
5.
Zurück zum Zitat Lerman A, Eeckhout E (2006) Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it? Eur Heart J 27:125–126PubMedCrossRef Lerman A, Eeckhout E (2006) Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it? Eur Heart J 27:125–126PubMedCrossRef
6.
Zurück zum Zitat Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ (2008) Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus paclitaxel-eluting stent. J Am Coll Cardiol Interv 1:65–71CrossRef Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ (2008) Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus paclitaxel-eluting stent. J Am Coll Cardiol Interv 1:65–71CrossRef
7.
Zurück zum Zitat Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW (2006) Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27:166–170PubMedCrossRef Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW (2006) Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27:166–170PubMedCrossRef
8.
Zurück zum Zitat Togni M, Raber L, Cocchia R, Wenaweser P, Cook S, Windecker S, Meier B, Hess OM (2007) Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 120:212–220PubMedCrossRef Togni M, Raber L, Cocchia R, Wenaweser P, Cook S, Windecker S, Meier B, Hess OM (2007) Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 120:212–220PubMedCrossRef
9.
Zurück zum Zitat Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46:231–236PubMedCrossRef Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46:231–236PubMedCrossRef
10.
Zurück zum Zitat Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, Masutani M, Lee-Kawabata M, Tsujino T, Ohyanagi M, Masuyama T (2011) Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 97:977–982PubMedCrossRef Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, Masutani M, Lee-Kawabata M, Tsujino T, Ohyanagi M, Masuyama T (2011) Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 97:977–982PubMedCrossRef
11.
Zurück zum Zitat Obata JE, Kitta Y, Takano H, Kodama Y, Nakamura T, Mende A, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Yano T, Kugiyama K (2007) Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 50:1305–1309PubMedCrossRef Obata JE, Kitta Y, Takano H, Kodama Y, Nakamura T, Mende A, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Yano T, Kugiyama K (2007) Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 50:1305–1309PubMedCrossRef
12.
Zurück zum Zitat Kim BK, Kim JS, Park JB, Ko YG, Choi D, Jang Y, Hong MK (2012) Comparison of optical coherence tomographic assessment between first- versus second-generation drug-eluting stents. Yonsei Med J 53:524–529PubMedCentralPubMedCrossRef Kim BK, Kim JS, Park JB, Ko YG, Choi D, Jang Y, Hong MK (2012) Comparison of optical coherence tomographic assessment between first- versus second-generation drug-eluting stents. Yonsei Med J 53:524–529PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, Ohba T, Mizuno K (2007) Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99:1033–1038PubMedCrossRef Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, Ohba T, Mizuno K (2007) Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99:1033–1038PubMedCrossRef
14.
Zurück zum Zitat Davlouros PA, Mavronasiou E, Xanthopoulou I, Karantalis V, Tsigkas G, Hahalis G, Alexopoulos D (2012) An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. Int J Cardiol 157:341–346PubMedCrossRef Davlouros PA, Mavronasiou E, Xanthopoulou I, Karantalis V, Tsigkas G, Hahalis G, Alexopoulos D (2012) An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. Int J Cardiol 157:341–346PubMedCrossRef
15.
Zurück zum Zitat Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, Hong MK (2012) Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging 28:705–714PubMedCrossRef Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, Hong MK (2012) Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging 28:705–714PubMedCrossRef
16.
Zurück zum Zitat Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, Koiwaya H, Ohtsuka M, Nakayoshi T, Itaya N, Chibana H, Kakuma T, Imaizumi T (2012) Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. J Am Coll Cardiol Interv 5:966–973CrossRef Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, Koiwaya H, Ohtsuka M, Nakayoshi T, Itaya N, Chibana H, Kakuma T, Imaizumi T (2012) Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. J Am Coll Cardiol Interv 5:966–973CrossRef
17.
Zurück zum Zitat Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906PubMedCrossRef Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906PubMedCrossRef
18.
Zurück zum Zitat Thanyasiri P, Kathir K, Celermajer DS, Adams MR (2007) Endothelial dysfunction and restenosis following percutaneous coronary intervention. Int J Cardiol 119:362–367PubMedCrossRef Thanyasiri P, Kathir K, Celermajer DS, Adams MR (2007) Endothelial dysfunction and restenosis following percutaneous coronary intervention. Int J Cardiol 119:362–367PubMedCrossRef
19.
Zurück zum Zitat Sabate M, Kay IP, van Der Giessen WJ, Cequier A, Ligthart JM, Gomez-Hospital JA, Carlier SG, Coen VL, Marijnissen JP, Wardeh AJ, Levendag PC, Serruys PW (1999) Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation. Circulation 100:1623–1629PubMedCrossRef Sabate M, Kay IP, van Der Giessen WJ, Cequier A, Ligthart JM, Gomez-Hospital JA, Carlier SG, Coen VL, Marijnissen JP, Wardeh AJ, Levendag PC, Serruys PW (1999) Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation. Circulation 100:1623–1629PubMedCrossRef
20.
Zurück zum Zitat Togni M, Windecker S, Wenaweser P, Tueller D, Kaisaier A, Maier W, Meier B, Hess OM (2004) Deleterious effect of coronary brachytherapy on vasomotor response to exercise. Circulation 110:135–140PubMedCrossRef Togni M, Windecker S, Wenaweser P, Tueller D, Kaisaier A, Maier W, Meier B, Hess OM (2004) Deleterious effect of coronary brachytherapy on vasomotor response to exercise. Circulation 110:135–140PubMedCrossRef
21.
Zurück zum Zitat Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK (2011) Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 161:367–372PubMedCrossRef Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK (2011) Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 161:367–372PubMedCrossRef
22.
Zurück zum Zitat Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, Ntalianis A, Muller O, Barbato E, Beleslin B, Sagic D, De Bruyne B, Bartunek J, Wijns W (2008) Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 1:193–200PubMedCrossRef Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, Ntalianis A, Muller O, Barbato E, Beleslin B, Sagic D, De Bruyne B, Bartunek J, Wijns W (2008) Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 1:193–200PubMedCrossRef
23.
Zurück zum Zitat Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ, Ferrante G, Wandel S, Windecker S, van Es GA, Eerdmans P, Juni P, di Mario C (2010) An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 31:165–176PubMedCrossRef Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ, Ferrante G, Wandel S, Windecker S, van Es GA, Eerdmans P, Juni P, di Mario C (2010) An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 31:165–176PubMedCrossRef
24.
Zurück zum Zitat Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, Sawada T, Miyoshi N, Kawamori H, Yoshino N, Hirata K (2009) Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 73:1033–1037PubMedCrossRef Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, Sawada T, Miyoshi N, Kawamori H, Yoshino N, Hirata K (2009) Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 73:1033–1037PubMedCrossRef
25.
Zurück zum Zitat Shimokawa H (2002) Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 39:319–327PubMedCrossRef Shimokawa H (2002) Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 39:319–327PubMedCrossRef
26.
Zurück zum Zitat Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T, Miyamoto Y, Saito Y, Nakao K, Yasue H, Ogawa H (2006) A-786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine. Pharmacogenet Genomics 16:339–345PubMedCrossRef Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T, Miyamoto Y, Saito Y, Nakao K, Yasue H, Ogawa H (2006) A-786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine. Pharmacogenet Genomics 16:339–345PubMedCrossRef
27.
Zurück zum Zitat Tanaka A, Shimada K, Tearney GJ, Kitabata H, Taguchi H, Fukuda S, Kashiwagi M, Kubo T, Takarada S, Hirata K, Mizukoshi M, Yoshikawa J, Bouma BE, Akasaka T (2011) Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. J Am Coll Cardiol 58:1608–1613PubMedCentralPubMedCrossRef Tanaka A, Shimada K, Tearney GJ, Kitabata H, Taguchi H, Fukuda S, Kashiwagi M, Kubo T, Takarada S, Hirata K, Mizukoshi M, Yoshikawa J, Bouma BE, Akasaka T (2011) Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. J Am Coll Cardiol 58:1608–1613PubMedCentralPubMedCrossRef
Metadaten
Titel
Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography
verfasst von
Hoyoun Won
Jung-Sun Kim
Dong-Ho Shin
Byeong-Keuk Kim
Young-Guk Ko
Donghoon Choi
Yangsoo Jang
Myeong-Ki Hong
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 2/2014
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-013-0325-4

Weitere Artikel der Ausgabe 2/2014

The International Journal of Cardiovascular Imaging 2/2014 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.